|
Publications
1. Kumar RA,
Karamohamed S, Sudi J,
Conrad DF,
Brune C,
Badner JA,
Gilliam
TC, Nowak NJ,
Cook EH
Jr, Dobyns WB,
Christian
SL. (2007) Recurrent 16p11.2 microdeletions in autism. Hum
Mol Genet. Dec 21.
2. Djousse L, Karamohamed S, Herbert AG, D'Agostino RB,
Cupples LA,
Ellison RC. Fucosyltransferase 3 polymorphism and
atherothrombotic disease in the Framingham Offspring Study. Am Heart J.
2007 Apr;153(4):636-9.
3.
Tobin JE,
Cui J,
Wilk JB,
Latourelle JC,
Laramie JM,
McKee AC,
Guttman M, Karamohamed S,
Myers RH. (2007). Sepiapterin reductase expression is increased in Parkinson's
disease brain tissue. Brain Res.
4. Wilk JB,Herbert A, Shoemaker CM, Gottlieb DJ,
Karamohamed S. (2007) Secreted Modular Calcium-Binding Protein 2 Haplotypes are Associated
with Pulmonary Function. Am J Respir Crit
Care Med. 175(6):554-60.
5. Herbert A, Karamohamed S, Liu J, Manning A, Fox CS,
Meigs JB, Cupples LA. (2006) BMI modifies associations of IL-6
genotypes with insulin resistance: the Framingham Study. Obesity (Silver
Spring). 2006 Aug;14(8):1454-61.
6. A. Herbert, C.
Liu, S.
Karamohamed, J. Schiller, J. Liu, Q. Yang, P. W. F. Wilson,
L. A. Cupples and J. B. Meigs. (2005). The –174 IL6 GG genotype is associated with a reduced risk of Type 2
Diabetes Mellitus in a family sample from the NHLBI Framingham Heart Study.
Diabetologia. Accepted.
7. S.
Karamohamed, J.C. Latourelle, J.B. Wilk, A.L. DeStefano, B.A.
Racette J.S. Perlmutter G.F. Wooten, M. Lew, C.
Klein, et al. BDNF genetic variants are associated with familial
Parkinson's disease in the GenePD
study. (2005). Neurology.
8. S. Karmohamed, L.I. Golbe, M.H. Mark, A.M. Lazzarini, et al. (2004) |
